These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 32716662)
1. Serum suPAR associated with disease severity and mortality in elderly patients with community-acquired pneumonia. Song S; Jia Q; Chen X; Lei Z; He X; Leng Z; Chen S Scand J Clin Lab Invest; 2020 Oct; 80(6):515-522. PubMed ID: 32716662 [TBL] [Abstract][Full Text] [Related]
2. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study. Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632 [TBL] [Abstract][Full Text] [Related]
3. Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia. Tsai PK; Tsao SM; Yang WE; Yeh CB; Wang HL; Yang SF Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30901954 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department]. Chen Y; Li C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403 [TBL] [Abstract][Full Text] [Related]
5. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED. Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103 [TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality. Zimmermann HW; Reuken PA; Koch A; Bartneck M; Adams DH; Trautwein C; Stallmach A; Tacke F; Bruns T J Intern Med; 2013 Jul; 274(1):86-100. PubMed ID: 23432143 [TBL] [Abstract][Full Text] [Related]
7. Soluble urokinase plasminogen activator receptor: an indicator of pneumonia severity in children. Wrotek A; Jackowska T; Pawlik K Adv Exp Med Biol; 2015; 835():1-7. PubMed ID: 25315615 [TBL] [Abstract][Full Text] [Related]
8. Improving prognostication of pneumonia among elderly patients: usefulness of suPAR. Ulaj A; Ibsen A; Azurmendi L; Sanchez JC; Prendki V; Roux X BMC Geriatr; 2024 Aug; 24(1):709. PubMed ID: 39182045 [TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis. Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112 [TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia. El-Mekkawy MS; Soliman SE; Saleh NY Turk J Pediatr; 2022; 64(1):98-109. PubMed ID: 35286036 [TBL] [Abstract][Full Text] [Related]
11. Predictive Value of Lysophosphatidylcholine for Determining the Disease Severity and Prognosis of Elderly Patients with Community-Acquired Pneumonia. Gu M; Lv S; Song Y; Wang H; Zhang X; Liu J; Liu D; Han X; Liu X Clin Interv Aging; 2024; 19():517-527. PubMed ID: 38528884 [TBL] [Abstract][Full Text] [Related]
12. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia. España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199 [TBL] [Abstract][Full Text] [Related]
13. Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia? Akpınar EE; Hoşgün D; Akpınar S; Ateş C; Baha A; Gülensoy ES; Ogan N J Bras Pneumol; 2019 Aug; 45(4):e20180417. PubMed ID: 31411279 [TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity. Lipinski M; Rydzewska-Rosolowska A; Rydzewski A; Cicha M; Rydzewska G Pancreatology; 2017; 17(1):24-29. PubMed ID: 27914940 [TBL] [Abstract][Full Text] [Related]
16. Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children. Wrotek A; Pawlik K; Jackowska T Adv Exp Med Biol; 2013; 788():329-34. PubMed ID: 23835994 [TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis. Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228 [TBL] [Abstract][Full Text] [Related]
18. Admission lysophosphatidylethanolamine acyltransferase level predicts the severity and prognosis of community-acquired pneumonia. Chen L; Zhao L; Shang Y; Xu Y; Gao Z Infection; 2021 Oct; 49(5):877-888. PubMed ID: 33694084 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum pregnancy-associated plasma protein A level at the initial ED presentation in elderly patients with CAP. Golcuk Y; Golcuk B; Bilge A; Korkmaz A; Irik M; Hayran M; Ozdemir AT; Kurtulmus Y Am J Emerg Med; 2015 Sep; 33(9):1232-6. PubMed ID: 26113245 [TBL] [Abstract][Full Text] [Related]
20. Cold-inducible RNA-binding protein might determine the severity and the presences of major/minor criteria for severe community-acquired pneumonia and best predicted mortality. Guo Q; Song WD; Li HY; Li M; Chen XK; Liu H; Peng HL; Yu HQ; Liu N; Lü ZD; Liang LH; Zhao QZ; Jiang M Respir Res; 2020 Jul; 21(1):192. PubMed ID: 32689999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]